Xconomy | Boston - Business + Technology in the Exponential Economy

Alkermes Regains Vivitrol Rights, Biogen Idec Heads for the Burbs, A Peek at Partners Innovation Fund’s Portfolio, & More Boston-Area Life Sciences News
Helicos Cuts 30 Percent of Workforce
Helicos Looking to Grow in Bay State, Thanks to Gov. Patrick’s Life Sciences Initiative
Helicos Promotes Steve Lombardi to CEO
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News

Helicos Shuffles CEOs, Names Lowy to Top Job

Helicos Biosciences, (NASDAQ: HLCS) the Cambridge, MA-based maker of genetic analysis tools, said it has hired Ronald Lowy as CEO, replacing Steve Lombardi, who was promoted to the top job in August. Lombardi will continue working at the company as president and as a member of the board, while concentrating on commercializing the HeliScope product line, the company said in a statement. Lowy, who joined the Helicos board in November 2007, is the former CEO of Fisher Biosciences, a division of Fisher Scientific. (Update: Helicos said Lowy will perform his CEO duties on a part-time basis, according to a regulatory filing issued later in the day.)

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.

Comments | Reprints | Share: